SCIENTURE HOLDINGS, INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
SCIENTURE HOLDINGS, INC. (SCNX) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $0.00 per share for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2020-03-30
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2019-03-31 was $0.00.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2018-09-30 was $0.01.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2018-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2018 was $0.02, a 100.00% increase from fiscal 2017.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2017 was $0.01.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-13 | ||||
| 2018-12-31 | $0.02 10-K · filed 2020-03-30 | $0.00 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $0.01 10-Q · filed 2019-10-28 | $0.01 10-Q · filed 2019-10-28 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-26 | $0.00 10-Q · filed 2019-07-26 | |||
| 2017-12-31 | $0.01 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |